Panion presents for investors at InvestorDagen in Aarhus, DK on the 12.th of June 2018
Panion Animal Health AB is a Swedish registered company with shares on Spotlight/AktieTorget and with a unique product in development – a gene therapy treatment for epilepsy in dogs. We have
a strong Scandinavian cooperation in that half of Panion’s management and board resides in Denmark. A safety study in dogs is currently running in Denmark in cooperation with the University of Copenhagen and under the lead of Associate professor David Woldbye, Department of neuroscience, KU.
Panion will increase its visibility towards Danish investors and the Danish market. At the investor-event held by the Danish shareholders association “Dansk Aktionærforening” on the 12.th of June 2018, the CEO Anja Holm will present Panion’s development and plans for existing shareholders and new investors.
The meeting takes place in Aarhus, Denmark, and all interested persons are welcome to the presentations and for a talk at Panion’s stand.
With Panion’s VIP-code, access to the event is free – please ask for the VIP-code by e-mail to:
anja.holm@panion-animalhealth.com
“We look forward to sharing our idea and business plans at the investor event and hope to meet as many new faces as possible. Please take advantage of our offer for free access to the entire event with the VIP-code. Information to Danish investors is even more relevant now that Spotlight Stock Market/AktieTorget will start up activities in the Danish market later this year.” says CEO of Panion, Anja Holm.
Details of the meeting:
http://www.shareholders.dk/investordagen
Tuesday 12.th of June 2018, @10-18
Radisson Blu Scandinavia Hotel
Margrethepladsen 1
8000 Aarhus, DK
Anja E. H. Holm, CEO
+ 45-22 94 66 00
anja.holm@panion-animalhealth.com
Bolaget ska utveckla och kommersialisera genterapi för behandling av epilepsiliknande tillstånd hos hundar och andra djur, samt utveckla och kommersialisera andra veterinärmedicinska produkter och nya behandlingsformer som kan ge sjuka djur bättre livskvalitet.
Panion will develop and commercialize a gene therapy treatment for dogs with drug refractory epilepsy, and other new animal health products and treatments that improve the quality of life for animals suffering from chronic diseases.